Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Bayer Stops Sale of Glucose Meter Business

01/09/2013 | 07:07am US/Eastern

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at

Subscribe to WSJ:

Stocks mentioned in the article : Bayer AG, SANOFI
Latest news on BAYER AG
10h ago BAYER : CropScience hosts Corn & Soybean Future Forum in Frankfurt -- Leading co..
1d ago BAYER : News Conference Call for the Third Quarter of 2014 -- Address by Dr. Mar..
1d ago MERCK : Bayer says eyeing more deals after bulking up consumer care
1d ago Bayer third-quarter adjusted profit gains slightly on strong crop chemicals
2d agoDJMaterials Down After Relatively Hawkish Fed Statement -- Materials Roundup
2d ago Bayer CropScience Acquires Certain DuPont Crop Protection Land Management Bus..
2d ago BAYER CROPSCIENCE : Launches Non-Selective Herbicide Specticle Total
3d ago BAYER : MaterialScience - Energy-efficient and cost-effective street lighting
4d ago Weak Merck sales overshadow third quarter cost cuts
4d ago Weak Merck sales overshadow third-quarter cost cuts
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes